JULY 26, 2019

New HIV Vaccine, Prevention Trials Show ‘Holy Grail’ Getting Closer

By Marie Rosenthal, MS

The ‘Holy Grail’ of HIV—preventing infections entirely—is moving forward. New studies released at the 10th IAS Conference on HIV Science (IAS 2019) place the spotlight on progress that could completely change the HIV prevention landscape by preventing the infection in the first place.

These include advancements in oral pre-exposure prophylaxis (PrEP) delivery, long-acting implants and vaccines.